Format

Send to

Choose Destination
Maturitas. 2016 Nov;93:108-113. doi: 10.1016/j.maturitas.2016.08.001. Epub 2016 Aug 16.

Cognitive decline: A vitamin B perspective.

Author information

1
Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, P.O. Box 14426, Melbourne VIC 8001, Australia.
2
University Cardiology Clinic, Medical School, Skopje, Macedonia.
3
Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, P.O. Box 14426, Melbourne VIC 8001, Australia. Electronic address: vasso.apostolopoulos@vu.edu.au.

Abstract

Cognitive decline is one of the major causes of disability in older people. A high level of homocysteine, a byproduct of vitamin B, has been linked to brain atrophy, which itself is a precursor to cognitive decline leading to dementia and Alzheimer's disease. In addition, a low level of vitamin B is often noted in patients with dementia and Alzheimer's disease and its supplementation has been shown to improve memory and to slow the progress of brain atrophy. This information may aid in the use of vitamin B as a preventative measure against severe cognitive decline, and thus reduce the onset of conditions such as dementia and Alzheimer's disease.

KEYWORDS:

Ageing; Gerontology; Immune cells; Immune system; Inflammation

PMID:
27574726
DOI:
10.1016/j.maturitas.2016.08.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center